comparemela.com

Latest Breaking News On - Rachel kobos - Page 1 : comparemela.com

FDA Approvals in the Blood Cancer Space from Winter 2024

The Food and Drug Administration approved multiple new therapies for blood cancer over the last few months.

Texas
United-states
Philadelphia
Pennsylvania
Rachel-kobos
Tanya-siddiqi
Elias-jabbour
Drug-administration
University-of-texas-md-anderson-cancer-center
School-of-hematologic-oncology-annual-meeting
City-of-hope-national-medical-center
Hematologic-oncology-annual-meeting

FDA Approval Highlights: OncLive's February Recap

In case you missed it, below is a recap of all drugs that have been approved by the FDA in February 2024.

University-of-chicago
Illinois
United-states
Tampa
Florida
Boston
Massachusetts
California
Connecticut
Los-angeles
Dana-farber-cancer-institute
New-haven

Johnson & Johnson's Tecvayli receives FDA approval for reduced dosing in multiple myeloma patients

Johnson & Johnson's Tecvayli receives FDA approval for reduced dosing in multiple myeloma patients
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Rachel-kobos
Johnson
Drug-administration
European-commission

Teclistamab Approved for Biweekly Dosing in R/R Multiple Myeloma

The bispecific antibody is used to treat patients with relapsed or refractory multiple myeloma (R/R MM) who have achieved and maintained a complete response for at least 6 months; this approval allows a dosing frequency of 1.5 mg/kg every 2 weeks.

United-states
Johnson-teclistamab
Rachel-kobos
Oncology-research-development
Johnson
Oncology-research
Johnson-innovative-medicine
Teclistamab
Multiple-myeloma
Bispecific

Johnson & Johnson's multiple myeloma therapy receives FDA approval for reduced dosing

Johnson & Johnson's multiple myeloma therapy receives FDA approval for reduced dosing
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Rachel-kobos
Johnson
Drug-administration
European-commission

vimarsana © 2020. All Rights Reserved.